Neoadjuvant Pembrolizumab plus Chemotherapy Vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab Vs Placebo for Early Tnbc: Surgical Outcomes from the Phase 3 Keynote-522 Study
AuthID
P-00Y-S50
P-00Y-S50